A.I. Ally

1.2k total citations
43 papers, 980 citations indexed

About

A.I. Ally is a scholar working on Pharmacology, Physiology and Molecular Biology. According to data from OpenAlex, A.I. Ally has authored 43 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 13 papers in Physiology and 11 papers in Molecular Biology. Recurrent topics in A.I. Ally's work include Inflammatory mediators and NSAID effects (20 papers), Nitric Oxide and Endothelin Effects (12 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). A.I. Ally is often cited by papers focused on Inflammatory mediators and NSAID effects (20 papers), Nitric Oxide and Endothelin Effects (12 papers) and Eicosanoids and Hypertension Pharmacology (9 papers). A.I. Ally collaborates with scholars based in Canada, United States and Sweden. A.I. Ally's co-authors include David F. Horrobin, Reginald O. Morgan, M.S. Manku, Rashida A. Karmali, Morris Karmazyn, Stephen C. Cunnane, Thomas E. Eling, K. Nakatsu, Bruce A. Pappas and Beth Tainer and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Environmental Health Perspectives and Endocrinology.

In The Last Decade

A.I. Ally

43 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.I. Ally Canada 18 307 203 185 145 136 43 980
A.L. Gimeno Argentina 21 302 1.0× 311 1.5× 319 1.7× 224 1.5× 165 1.2× 146 1.7k
G. Abou-Mohamed United States 12 218 0.7× 170 0.8× 300 1.6× 105 0.7× 74 0.5× 23 873
J M Sneddon United Kingdom 14 345 1.1× 175 0.9× 331 1.8× 203 1.4× 83 0.6× 30 1.2k
J. M. Armstrong United Kingdom 13 266 0.9× 251 1.2× 193 1.0× 163 1.1× 204 1.5× 36 840
H. Heath United Kingdom 21 487 1.6× 172 0.8× 156 0.8× 66 0.5× 67 0.5× 52 1.1k
A. Bizzi Italy 21 257 0.8× 140 0.7× 235 1.3× 61 0.4× 68 0.5× 60 1.0k
Robin Hoult United Kingdom 10 625 2.0× 227 1.1× 384 2.1× 134 0.9× 108 0.8× 15 1.5k
Jerome H. Fleisch United States 18 448 1.5× 141 0.7× 520 2.8× 164 1.1× 110 0.8× 51 1.2k
Michael L. Selley Australia 20 437 1.4× 85 0.4× 383 2.1× 129 0.9× 161 1.2× 26 1.8k
Lennart Lundholm Sweden 18 324 1.1× 73 0.4× 323 1.7× 232 1.6× 45 0.3× 56 1.1k

Countries citing papers authored by A.I. Ally

Since Specialization
Citations

This map shows the geographic impact of A.I. Ally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.I. Ally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.I. Ally more than expected).

Fields of papers citing papers by A.I. Ally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.I. Ally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.I. Ally. The network helps show where A.I. Ally may publish in the future.

Co-authorship network of co-authors of A.I. Ally

This figure shows the co-authorship network connecting the top 25 collaborators of A.I. Ally. A scholar is included among the top collaborators of A.I. Ally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.I. Ally. A.I. Ally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ally, A.I., Richard Buist, Paul C. Mills, & Kenneth R. Reuhl. (1993). Effects of methylmercury and trimethyltin on cardiac, platelet, and aorta eicosanoid biosynthesis and platelet serotonin release. Pharmacology Biochemistry and Behavior. 44(3). 555–563. 9 indexed citations
3.
Ally, A.I., et al.. (1992). Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 575(1). 19–27. 92 indexed citations
4.
Pappas, Bruce A., et al.. (1992). Enriched environment primes forebrain choline acetyltransferase activity to respond to learning experience. Neuroscience Letters. 143(1-2). 259–262. 58 indexed citations
5.
Pappas, Bruce A., et al.. (1992). Neonatal brain dopamine depletion and the cortical and behavioral consequences of enriched postweaning environment. Pharmacology Biochemistry and Behavior. 42(4). 741–748. 18 indexed citations
6.
Whitfield, J. F., et al.. (1990). Carcinogenic implications of the neighborhood coherence principle (NCP). Medical Hypotheses. 31(4). 289–301. 7 indexed citations
7.
Ally, A.I. & D.F. Horrobin. (1986). Hydralazine inhibits vascular reactivity by a mechanism independent of vascular prostaglandin biosynthesis: role of thromboxane synthetase in blocking hydralazine actions.. PubMed. 53(1). 39–63. 2 indexed citations
8.
Eling, Thomas E. & A.I. Ally. (1984). Pulmonary biosynthesis and metabolism of prostaglandins and related substances.. Environmental Health Perspectives. 55. 159–168. 18 indexed citations
9.
Ally, A.I., et al.. (1984). The effect of methylmercuric chloride on arachidonic acid metabolism by platelet lipoxygenase. Prostaglandins Leukotrienes and Medicine. 15(2). 209–221. 6 indexed citations
10.
Horrobin, David F., Reginald O. Morgan, Rashida A. Karmali, et al.. (1979). THYMIC CHANGES IN MUSCULAR DYSTROPHY AND EVIDENCE FOR AN ABNORMALITY RELATED TO PROSTAGLANDIN SYNTHESIS OR ACTION *. Annals of the New York Academy of Sciences. 317(1). 534–549. 11 indexed citations
11.
Cunnane, Stephen C., Helmut Zinner, David F. Horrobin, et al.. (1979). Copper inhibits pressor responses to noradrenaline but not potassium. Interactions with prostaglandins E1, E2, and I2 and penicillamine. Canadian Journal of Physiology and Pharmacology. 57(1). 35–40. 15 indexed citations
12.
Ally, A.I., M.S. Manku, David F. Horrobin, et al.. (1978). Thromboxane A2 as a possible natural ligand for benzodiazepine receptors. Neuroscience Letters. 7(1). 31–34. 27 indexed citations
13.
Manku, M.S., David F. Horrobin, Stephen C. Cunnane, et al.. (1978). Prostaglandins E1, E2 and I2: Evidence for three distinct actions in vascular smooth muscle. Biochemical and Biophysical Research Communications. 83(1). 295–299. 22 indexed citations
14.
Karmazyn, Morris, David F. Horrobin, M.S. Manku, et al.. (1978). Effects of prostacyclin on perfusion pressure, electrical activity, rate and force of contraction in isolated rat and rabbit hearts. Life Sciences. 22(23). 2079–2085. 27 indexed citations
15.
Horrobin, David F., Rashida A. Karmali, M.S. Manku, et al.. (1978). A defect in thromboxane a2 synthesis may be a factor predisposing to cancer. Prostaglandins and Medicine. 1(2). 175–181. 5 indexed citations
16.
Ally, A.I., David F. Horrobin, M.S. Manku, et al.. (1978). Dantrolene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2. Canadian Journal of Physiology and Pharmacology. 56(3). 520–523. 24 indexed citations
17.
Ally, A.I., et al.. (1977). Dipyridamole: A possible potent inhibitor of thromboxane A2 synthetase in vascular smooth muscle. Prostaglandins. 14(3). 607–609. 46 indexed citations
18.
Ally, A.I., David F. Horrobin, Rashida A. Karmali, et al.. (1977). Adenosine as a natural prostaglandin antagonist in vascular smooth muscle. Prostaglandins. 14(1). 109–117. 16 indexed citations
19.
Horrobin, David F., M.S. Manku, Morris Karmazyn, et al.. (1977). Quinacrine is a prostaglandin antagonist. Biochemical and Biophysical Research Communications. 76(4). 1188–1193. 24 indexed citations
20.
Ally, A.I. & K. Nakatsu. (1976). Adenosine inhibition of isolated rabbit ileum and antagonism by theophylline.. Journal of Pharmacology and Experimental Therapeutics. 199(1). 208–215. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026